{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:13:47Z","timestamp":1788455627451,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","award":["225485\/Z\/22\/Z"],"award-info":[{"award-number":["225485\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220171\/Z\/20\/Z"],"award-info":[{"award-number":["220171\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220549\/Z\/20\/Z"],"award-info":[{"award-number":["220549\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","award":["CC2223"],"award-info":[{"award-number":["CC2223"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006149","name":"Oxford University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jinf.2025.106601","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:28:38Z","timestamp":1755764918000},"page":"106601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-4704","authenticated-orcid":false,"given":"Louise O.","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-2367","authenticated-orcid":false,"given":"Marion","family":"Delphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-901X","authenticated-orcid":false,"given":"Marije","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila F.","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-3845","authenticated-orcid":false,"given":"Elizabeth","family":"Waddilove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6401-0732","authenticated-orcid":false,"given":"Jacqueline","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"de Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arran","family":"Babbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-1074","authenticated-orcid":false,"given":"Monique I.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Glashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dusheiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantjie","family":"Taljaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-7910","authenticated-orcid":false,"given":"Wolfgang","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongai G.","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106601_bib1","unstructured":"Global hepatitis report 2024: action for access in low- and middle-income countries; 2024. Available at \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240091672\u3009. Accessed September 5, 2024."},{"key":"10.1016\/j.jinf.2025.106601_bib2","unstructured":"Goal 3. Available at \u3008https:\/\/sdgs.un.org\/goals\/goal3\u3009. Accessed September 19, 2024."},{"key":"10.1016\/j.jinf.2025.106601_bib3","unstructured":"Overview | Hepatitis B (chronic): diagnosis and management | Guidance | NICE. Available at \u3008https:\/\/www.nice.org.uk\/guidance\/cg165\u3009. Accessed August 30, 2023."},{"issue":"2","key":"10.1016\/j.jinf.2025.106601_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jinf.2025.106601_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2025.106601_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.26041","article-title":"Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads","volume":"57","author":"Tseng","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jinf.2025.106601_bib8","unstructured":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Available at \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240090903\u3009. Accessed April 26, 2024."},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib9","doi-asserted-by":"crossref","first-page":"A247.1","DOI":"10.1136\/gutjnl-2014-307263.531","article-title":"PTH-085 systematic review of performance of alt in predicting liver fibrosis: Alt is A sensitive, but not A specific marker of liver fibrosis in populations with\/suspected liver disease","volume":"63","author":"Coad","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2025.106601_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/IJGM.S309311","article-title":"Correlation of serum transaminase levels with liver fibrosis assessed by transient elastography in Vietnamese patients with nonalcoholic fatty liver disease","volume":"14","author":"Thong","year":"2021","journal-title":"Int J Gen Med"},{"issue":"4","key":"10.1016\/j.jinf.2025.106601_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","volume":"20","author":"Lim","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"104992","key":"10.1016\/j.jinf.2025.106601_bib12","article-title":"Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B","volume":"185","author":"Issam","year":"2021","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.jinf.2025.106601_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3350\/cmh.2021.0012","article-title":"Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma","volume":"27","author":"Wu","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.jinf.2025.106601_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.40.2.439-445.2002","article-title":"Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load","volume":"40","author":"Kimura","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106601_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection","volume":"47","author":"Mak","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cgh.2020.04.045","article-title":"Hepatitis B core-related antigen to indicate high viral load: systematic review and meta-analysis of 10,397 individual participants","volume":"19","author":"Yoshida","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jinf.2025.106601_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.51","article-title":"Seven-year treatment outcome of entecavir in a real-world cohort: effects on clinical parameters, HBsAg and HBcrAg levels","volume":"8","author":"Lam","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"12","key":"10.1016\/j.jinf.2025.106601_bib19","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/v14122671","article-title":"HBcrAg predicts hepatocellular carcinoma development in chronic B hepatitis related liver cirrhosis patients undergoing long-term effective anti-viral","volume":"14","author":"Chang","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.jinf.2025.106601_bib20","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/hep.32018","article-title":"Comparison of HBV RNA and hepatitis B core related antigen with conventional HBV markers among untreated adults with chronic hepatitis B in north America","volume":"74","author":"Ghany","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jinf.2025.106601_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2353","article-title":"Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: a mini systematic review of the literature","volume":"32","author":"Afifi","year":"2022","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.31026","article-title":"Pregenomic HBV RNA and hepatitis B core-related antigen predict outcomes in hepatitis B e antigen-negative chronic hepatitis B patients suppressed on nucleos(T)ide analogue therapy","volume":"72","author":"Carey","year":"2020","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jinf.2025.106601_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/1469-0691.12739","article-title":"Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B","volume":"20","author":"Seto","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.03.013","article-title":"HBcrAg predicts hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics","volume":"65","author":"Tada","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jinf.2025.106601_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(24)00083-9","article-title":"Equity in clinical trials for hepatitis B","volume":"9","author":"Mitchell","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106601_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(23)00315-1","article-title":"Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection","volume":"9","author":"Delphin","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jinf.2025.106601_bib27","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/cid\/ciz412","article-title":"Hepatitis B core-related antigen: an alternative to hepatitis B virus DNA to assess treatment eligibility in Africa","volume":"70","author":"Shimakawa","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2025.106601_bib28","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.cgh.2022.05.026","article-title":"Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings","volume":"21","author":"Shimakawa","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106601_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf125","article-title":"Hepatitis B core related antigen (HBcrAg) point of care tests as a risk stratification tool: experience from Kenya","volume":"12","author":"Downs","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5334\/aogh.2848","article-title":"Point-of-care tests for hepatitis B are associated with A higher linkage to care and lower cost compared to venepuncture sampling during outreach screenings in an Asian migrant population","volume":"86","author":"Ho","year":"2020","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.jinf.2025.106601_bib31","unstructured":"Matthews Philippa, Maponga Tongai, Goedhals Dominique. OXSAHEP Project Report. figshare; 2023."},{"issue":"3","key":"10.1016\/j.jinf.2025.106601_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00699-19","article-title":"Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection","volume":"10","author":"Downs","year":"2019","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib33","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/s41598-019-43524-9","article-title":"Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)","volume":"9","author":"McNaughton","year":"2019","journal-title":"Sci Rep"},{"issue":"104548","key":"10.1016\/j.jinf.2025.106601_bib34","article-title":"Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: an observational case series of South African adults","volume":"129","author":"Mokaya","year":"2020","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jinf.2020.04.037","article-title":"Treatment advantage in HBV\/HIV coinfection compared to HBV monoinfection in a South African cohort","volume":"81","author":"Maponga","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2025.106601_bib36","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"World Health Organization","year":"2015"},{"issue":"1","key":"10.1016\/j.jinf.2025.106601_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/biomet\/asaa052","article-title":"Jeffreys-prior penalty, finiteness and shrinkage in binomial-response generalized linear models","volume":"108","author":"Kosmidis","year":"2021","journal-title":"Biometrika"},{"issue":"4","key":"10.1016\/j.jinf.2025.106601_bib38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jgh.13989","article-title":"Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers","volume":"33","author":"Tada","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"32","key":"10.1016\/j.jinf.2025.106601_bib39","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.3748\/wjg.v25.i32.4764","article-title":"On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B","volume":"25","author":"Chang","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:27:26Z","timestamp":1772825246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0163445325002014"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106601","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106601"}}